Results 211 to 220 of about 53,280 (246)

87. Comparative Efficacy of Novel Disease-Modifying Antirheumatic Drugs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with an Inadequate Response to Traditional Dmards: A Network Meta-Analysis [PDF]

, 2017
Buckley, Felicity, Dejonckheere, Fred, Finckh, Axel, Huizinga, Tom W. J., Jansen, Jeroen P.   +4 more
core  

JAK3 inhibition: what potential for the future? [PDF]

core   +1 more source

IgA nephropathy with rheumatoid arthritis related to adalimumab. [PDF]

CEN Case Rep
Tüfekçi B, Kardaş RC, Öğüt B, Erden A.   +3 more
europepmc   +1 more source

Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review. [PDF]

Health Sci Rep
Jafarzadeh A, Darvishi MA, Khosravi M, Roohaninasab M, Goodarzi A.   +4 more
europepmc   +1 more source

Risk Factors for Major Adverse Cardiovascular Events, Malignancies, and Serious Infections With Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of a 3-Year J-Post-Marketing Surveillance. [PDF]

Int J Rheum Dis
Yamaoka K, Hoshi M, Endo Y, Hirano T.
europepmc   +1 more source

Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia. [PDF]

Cureus
Aleidi FA, Almadhi MO, Altassan ZH, Alotaibi LF, Almutairi B, Khalaf M, Almansour HM, Alhowil RR, Alotaibi A, Alsultani SA, Fahad R, Thawab F.   +11 more
europepmc   +1 more source

Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials. [PDF]

BMJ Open
Strand V, Schulze-Koops H, Al-Emadi S, Kinch CD, Gruben D, Germino R, Connell CA, Mysler E.   +7 more
europepmc   +1 more source

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis. [PDF]

Cureus
Burashed KK, AlAbbasi FA.
europepmc   +1 more source